Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

被引：6

作者：

Yi, Jun Ho ^{[1
]}

Kim, Seok Jin ^{[2
]}

Yoon, Dok Hyun ^{[3
]}

Suh, Cheolwon ^{[3
]}

Chang, Myung Hee ^{[4
]}

Yang, Deok Hwan ^{[5
]}

Jo, Jae-Cheol ^{[6
]}

Hyun, Shin Young ^{[7
]}

Eom, Hyeon-Seok ^{[8
]}

Lee, Jeong-Ok ^{[9
]}

Kwon, Ji Hyun ^{[10
]}

Han, Sang Hoon ^{[11
]}

Lee, Seung-Shin ^{[12
]}

Kwak, Jae-Yong ^{[13
]}

Kim, Se Hyung ^{[14
]}

Kim, Dae Sik ^{[15
]}

Lee, Ji Hyun ^{[16
]}

Oh, Sung Yong ^{[16
]}

Ryoo, Hun Mo ^{[17
]}

Kim, Hyo Jung ^{[18
]}

Kim, Won Seog ^{[2
]}

机构：

[1] Chung Ang Univ, Div Hematol Oncol, Dept Med, Seoul 06973, South Korea

[2] Sungkyunkwan Univ, Div Hematol & Oncol, Dept Med, Samsung Med Ctr,Sch Med, 50 Irwon Dong, Seoul 06351, South Korea

[3] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul 05505, South Korea

[4] Natl Hlth Insurance Corp Ilsan Hosp, Goyang 10444, South Korea

[5] Chonnam Natl Univ, Sch Med, Dept Hematooncol, Hwasun Hosp, Hwasun 58128, Gwangju, South Korea

[6] Univ Ulsan, Dept Hematol & Oncol, Ulsan Univ Hosp, Coll Med, Ulsan 44033, South Korea

[7] Yonsei Univ, Dept Internal Med, Coll Med, Wonju 26426, South Korea

[8] Natl Canc Ctr, Dept Internal Med, Gyeonggi Do 10408, Goyang, South Korea

[9] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam 13620, South Korea

[10] ChungBuk Natl Univ Hosp, Dept Internal Med, Chungbuk 28644, Cheongju, South Korea

[11] Jeju Natl Univ, Dept Internal Med, Jeju Natl Univ Hosp, Sch Med, Jeju 63241, South Korea

[12] Wonkwang Univ Hosp, Dept Hematol Oncol, Iksan 54538, South Korea

[13] Jeonbuk Natl Univ, Dept Internal Med, Sch Med, Jeonju 54907, South Korea

[14] Soonchunhyang Univ, Div Hematol Oncol, Dept Internal Med, Coll Med,Bucheon Hosp, Bucheon 14584, South Korea

[15] Korea Univ, Div Hematol Oncol, Dept Internal Med, Guro Hosp, Seoul 08308, South Korea

[16] Dong A Univ, Div Hematol Oncol, Dept Internal Med, Coll Med, Busan 49201, South Korea

[17] Catholic Univ Daegu, Dept Internal Med, Div Hematol Oncol, Daegu 42472, South Korea

[18] Hallym Univ, Div Hematol Oncol, Dept Internal Med, Sacred Heart Hosp,Coll Med, Anyang 14068, South Korea

来源：

CANCER COMMUNICATIONS | 2021年 / 41卷 / 03期

关键词：

D O I：

10.1002/cac2.12150

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：275 / 278

页数：4

共 50 条

[21] Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis
Yang, Ping
Cai, Qing-qing
Zhang, Wei
Liu, Shuo-zi
Liu, Hui
Sun, Xiu-hua
Dong, Yu-jun
Xiao, Xiu-bin
Wang, Jing-wen
Li, Zhen-ling
Huang, Wen-rong
Li, Li-hong
Bao, Hui-zheng
Yang, Wei
Wang, Ya-lan
Wang, Shu-ye
He, Juan
Li, Xiao-ling
Liu, Ai-chun
Jing, Hong-mei
CANCER MEDICINE, 2023, 12 (12): : 13204 - 13216
[22] A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
Sawalha, Yazeed
Goyal, Subir
Switchenko, Jeffrey M.
Romancik, Jason T.
Kamdar, Manali
Greenwell, I. Brian
Hess, Brian T.
Isaac, Krista M.
Portell, Craig A.
Garcia, Alex Mejia
Goldsmith, Scott
Grover, Natalie S.
Riedel, Peter A.
Karmali, Reem
Burkart, Madelyn
Buege, Michael
Akhtar, Othman
Torka, Pallawi
Kumar, Anita
Hill, Brian T.
Kahl, Brad S.
Cohen, Jonathon B.
BLOOD ADVANCES, 2023, 7 (13) : 2983 - 2993
[23] Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China
Cai, Qingqing
Huang, Huiqiang
Zhang, Yuchen
Liu, Panpan
Jing, Hongmei
Yang, Ping
Lin, Tongyu
Xia, Zhongjun
Li, Zhiming
Li, Wenyu
Zhong, Liye
Ye, Xu
Jin, Xueli
Zhang, Liling
Zhang, Huilai
Sun, Xiuhua
Tian, Yuyang
Ma, Shuyun
Su, Ning
Cai, Jun
BLOOD, 2020, 136
[24] Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory (R/R) mantle cell lymphoma (MCL).
Epperla, Narendranath
Hamadani, Mehdi
Ahn, Kwang Woo
Oak, Eunhye
Cashen, Amanda F.
Kanate, Abraham Sebastian
Calzada, Oscar
Farmer, Zachary Luke
Tallarico, Michael
Nabhan, Chadi
Costa, Luciano J.
Kenkre, Vaishalee Padgaonkar
Ghosh, Nilanjan
Cohen, Jonathon Brett
Hari, Parameswaran
Fenske, Timothy S.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[25] Treatment Patterns Among Patients With Mantle Cell Lymphoma and Comparison of Healthcare Resource Utilization and Costs Among Relapsed/Refractory Patients Treated With Ibrutinib or Chemoimmunotherapy: A Real-world Retrospective Study
Ghosh, Nilanjan
Emond, Bruno
Lafeuille, Marie-Helene
Cote-Sergent, Aurelie
Lefebvre, Patrick
Huang, Qing
CLINICAL THERAPEUTICS, 2021, 43 (08) : 1285 - 1299
[26] Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
Obr, Ales
Benesova, Katerina
Janikova, Andrea
Mocikova, Heidi
Belada, David
Hruskova, Andrea
Vockova, Petra
Salek, David
Sykorova, Alice
Furst, Tomas
Malarikova, Diana
Papajik, Tomas
Trneny, Marek
Klener, Pavel
ANNALS OF HEMATOLOGY, 2023, 102 (01) : 107 - 115
[27] Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
Ales Obr
Katerina Benesova
Andrea Janikova
Heidi Mocikova
David Belada
Andrea Hruskova
Petra Vockova
David Salek
Alice Sykorova
Tomas Furst
Diana Malarikova
Tomas Papajik
Marek Trneny
Pavel Klener
Annals of Hematology, 2023, 102 : 107 - 115
[28] Real-world experience of PD-1 inhibitors for relapsed and refractory Hodgkin lymphoma: A multicenter retrospective analysis of patients in China
Yu, Wenyan
Geng, Mei
Hao, Jie
Yan, Zeying
Mi, Jian-Qing
ACTA HAEMATOLOGICA, 2023, 146 (04) : 307 - 315
[29] Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphoma
Oyake, Tatsuo
Maeta, Takahiro
Takahata, Takenori
Tamai, Yoshiko
Kameoka, Yoshihiro
Takahashi, Naoto
Miyairi, Yasuro
Murai, Kazunori
Shimosegawa, Kenji
Yoshida, Kozue
Inokura, Kyoko
Fukuhara, Noriko
Harigae, Hideo
Sato, Ryo
Ishizawa, Kenichi
Tajima, Katsushi
Saitou, Souichi
Fukatsu, Masahiko
Ikezoe, Takayuki
Tsunoda, Saburo
Mita, Masayuki
Mori, Jinichi
Kowata, Shugo
Ito, Shigeki
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024, 64 (03) : 191 - 202
[30] The necessity of post-induction therapy in mantle cell lymphoma patients: A multicenter retrospective real-world analysis by Polish Lymphoma Research Group (PLRG)
Dlugosz-Danecka, Monika
Krawczyk, Katarzyna
Ochrem, Bogdan
Szymczyk, Michal
Joks, Monika
Boguradzki, Piotr
Giza, Agnieszka
Zimowska-Curylo, Dagmara
Mazur, Grzegorz
Jurczak, Wojciech
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 303 - 309

← 1 2 3 4 5 →